Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$4.12B |
| 2 |
Gilead Sciences
GILD
|
+$379M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$286M |
| 4 |
Amazon
AMZN
|
+$271M |
| 5 |
Meta Platforms (Facebook)
META
|
+$266M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$762M |
| 2 |
SPDR Gold Trust
GLD
|
+$410M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$400M |
| 4 |
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
|
+$227M |
| 5 |
Synchrony
SYF
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 2.31% |
| 2 | Technology | 1.26% |
| 3 | Financials | 1.12% |
| 4 | Healthcare | 1.04% |
| 5 | Consumer Discretionary | 0.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
iShares 0-5 Year TIPS Bond ETF
STIP
$16.1B
| $7.26M | ﹤0.01% |
71,792
+56,738
| +377% | +$5.73M |
|
1802
PUT
Alerian MLP ETF
AMLP
$13.4B
| $7.25M | ﹤0.01% |
114,280
-11,760
| -9% | -$744K |
|
1803
PUT
Criteo S.A.
CRTO
$831M
| $7.24M | ﹤0.01% |
206,300
+129,000
| +167% | +$5.11M |
|
|
ACOR
1804
CALL
DELISTED
Acorda Therapeutics
ACOR
| $7.24M | ﹤0.01% |
2,891
+2,517
| +673% | +$7.51M |
|
1805
Celanese
CE
$4.91B
| $7.24M | ﹤0.01% |
108,806
+7,811
| +8% | +$511K |
|
|
QVCGA
1806
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $7.24M | ﹤0.01% |
7,455
+7,070
| +1,836% | +$7.79M |
|
|
SAND
1807
CALL
DELISTED
Sandstorm Gold
SAND
| $7.24M | ﹤0.01% |
1,439,600
+1,386,600
| +2,616% | +$7.77M |
|
1808
PUT
Eagle Materials
EXP
$6.14B
| $7.24M | ﹤0.01% |
93,600
+53,800
| +135% | +$4.32M |
|
1809
CALL
Moody's
MCO
$89.1B
| $7.22M | ﹤0.01% |
66,700
-26,800
| -29% | -$2.82M |
|
|
LUMO
1810
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $7.21M | ﹤0.01% |
53,300
-15,022
| -22% | -$1.49M |
|
1811
Golar LNG
GLNG
$5.23B
| $7.2M | ﹤0.01% |
339,804
+26,586
| +8% | +$508K |
|
1812
HF Sinclair
DINO
$17.2B
| $7.2M | ﹤0.01% |
293,943
-63,221
| -18% | -$1.59M |
|
1813
CALL
Shake Shack
SHAK
$2.95B
| $7.2M | ﹤0.01% |
207,700
-86,800
| -29% | -$3.22M |
|
1814
CALL
JetBlue
JBLU
$1.88B
| $7.19M | ﹤0.01% |
417,300
+215,300
| +107% | +$3.68M |
|
|
VAL
1815
PUT
DELISTED
Valspar
VAL
| $7.19M | ﹤0.01% |
67,800
-41,600
| -38% | -$4.43M |
|
1816
CALL
Becton Dickinson
BDX
$51.8B
| $7.19M | ﹤0.01% |
41,000
-61,603
| -60% | -$10.5M |
|
|
BPL
1817
CALL
DELISTED
Buckeye Partners, L.P.
BPL
| $7.19M | ﹤0.01% |
100,400
-43,900
| -30% | -$3.12M |
|
1818
CALL
Public Storage
PSA
$59.3B
| $7.18M | ﹤0.01% |
32,200
-37,600
| -54% | -$8.78M |
|
1819
United Parcel Service
UPS
$89.9B
| $7.18M | ﹤0.01% |
65,700
| – | – |
|
|
FDC
1820
PUT
DELISTED
First Data Corporation
FDC
| $7.17M | ﹤0.01% |
544,700
+179,700
| +49% | +$2.32M |
|
|
PPL
1821
PUT
PPL Corp
PPL
$26.4B
| $7.16M | ﹤0.01% |
207,200
+95,200
| +85% | +$3.43M |
|
1822
United Airlines
UAL
$37.3B
| $7.16M | ﹤0.01% |
136,446
-653,565
| -83% | -$31.4M |
|
1823
PUT
Ziff Davis
ZD
$1.91B
| $7.15M | ﹤0.01% |
123,510
-31,740
| -20% | -$1.85M |
|
1824
CALL
ASML
ASML
$671B
| $7.14M | ﹤0.01% |
65,200
+29,500
| +83% | +$3.12M |
|
1825
PUT
Smith & Wesson
SWBI
$600M
| $7.14M | ﹤0.01% |
349,579
-110,325
| -24% | -$2.41M |
|
Similar funds
Jeff Yass's Q3 2016 Portfolio in Review
As of Q3 2016, Jeff Yass held 9,816 positions worth $207B, up 11% from $187B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass deployed $7.99B of net new capital in Q3 2016, opening 1,347 new positions and adding to 3,278 existing holdings. Its largest new stake was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
By sector, the portfolio is most concentrated in Consumer Staples at 2.3% of assets, up from 0.28% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $762M trimmed.
- Jeff Yass's largest Q3 2016 buy was Bristol-Myers Squibb: 4,459,411 shares worth $240M.
- Jeff Yass added most to Procter & Gamble in Q3 2016, an estimated $4.12B increase.
- Jeff Yass's biggest Q3 2016 reduction was Apple, cutting an estimated $762M.
- Jeff Yass fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $227M.
- Jeff Yass's ten largest holdings make up 27% of its $207B portfolio in Q3 2016.
- Jeff Yass opened 1,347 new positions and closed 1,488 in Q3 2016.
- Jeff Yass's portfolio value rose 11% quarter-over-quarter to $207B.
Based on Susquehanna International Group's 13F filing for Q3 2016, filed 14 Nov 2016.